The New Face of Traditional Chinese Medicine
Top Cited Papers
- 10 January 2003
- journal article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 299 (5604) , 188-190
- https://doi.org/10.1126/science.299.5604.188
Abstract
TOKYO-- This year, the U.S. Food and Drug Administration approved a phase II trial to test the efficacy of Kanglaite in treating non-small-cell lung cancer, making Kanglaite the first drug derived from a traditional Chinese herbal remedy to go into clinical trials in the United States. Asian governments are hoping that high-volume screening and rigorous clinical trials will unlock the secrets of ancient herbal remedies--and that the results will pass muster with Western scientists.Keywords
This publication has 0 references indexed in Scilit: